TY - JOUR
T1 - S3 Guideline Atopic dermatitis
T2 - Part 1 - General aspects, topical and non-drug therapies, special patient groups
AU - Werfel, Thomas
AU - Heratizadeh, Annice
AU - Aberer, Werner
AU - Augustin, Matthias
AU - Biedermann, Tilo
AU - Bauer, Andrea
AU - Fölster-Holst, Regina
AU - Kahle, Julia
AU - Kinberger, Maria
AU - Nemat, Katja
AU - Neustädter, Irena
AU - Peters, Eva
AU - von Kiedrowski, Ralph
AU - Schmid-Grendelmeier, Peter
AU - Schmitt, Jochen
AU - Schwennesen, Thomas
AU - Simon, Dagmar
AU - Spindler, Thomas
AU - Traidl-Hoffmann, Claudia
AU - Werner, Ricardo Niklas
AU - Wollenberg, Andreas
AU - Worm, Margitta
AU - Ott, Hagen
N1 - Publisher Copyright:
© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
PY - 2024
Y1 - 2024
N2 - This S3 guideline was created based on the European S3 guideline, with special consideration of the medical conditions in the German-speaking region and incorporating additions from the previous German-language version. The interdisciplinary guideline commission consisted of representatives from the German Dermatological Society, the Professional Association of German Dermatologists, the Austrian Society of Dermatology and Venereology, the Swiss Society of Dermatology and Venereology, the German Society for Allergology and Clinical Immunology, the German Society for Pediatric and Adolescent Medicine, the Professional Association of Pediatricians and Adolescent Medicine, the Society for Pediatric Allergology and Environmental Medicine, the German Society for Pediatric Rehabilitation and Prevention, the German Society for Psychosomatic Medicine and Medical Psychotherapy, the German Network for Health Services Research, the German Eczema Association and the German Allergy and Asthma Association. This first part of the guideline focuses on the definition and diagnostic aspects of atopic dermatitis (AD), addressing topical therapy as well as non-pharmacological treatment approaches such as UV therapy, psychoeducational therapy, dietary interventions for AD, allergen immunotherapy for AD, and complementary medicine. This part of the guideline also covers specific aspects of AD in children and adolescents, during pregnancy and lactation, and in the context of family planning. Additionally, it addresses occupational aspects of AD and highlights the perspective of the patients. The second part of the guideline, published separately, addresses the systemic therapy of AD.
AB - This S3 guideline was created based on the European S3 guideline, with special consideration of the medical conditions in the German-speaking region and incorporating additions from the previous German-language version. The interdisciplinary guideline commission consisted of representatives from the German Dermatological Society, the Professional Association of German Dermatologists, the Austrian Society of Dermatology and Venereology, the Swiss Society of Dermatology and Venereology, the German Society for Allergology and Clinical Immunology, the German Society for Pediatric and Adolescent Medicine, the Professional Association of Pediatricians and Adolescent Medicine, the Society for Pediatric Allergology and Environmental Medicine, the German Society for Pediatric Rehabilitation and Prevention, the German Society for Psychosomatic Medicine and Medical Psychotherapy, the German Network for Health Services Research, the German Eczema Association and the German Allergy and Asthma Association. This first part of the guideline focuses on the definition and diagnostic aspects of atopic dermatitis (AD), addressing topical therapy as well as non-pharmacological treatment approaches such as UV therapy, psychoeducational therapy, dietary interventions for AD, allergen immunotherapy for AD, and complementary medicine. This part of the guideline also covers specific aspects of AD in children and adolescents, during pregnancy and lactation, and in the context of family planning. Additionally, it addresses occupational aspects of AD and highlights the perspective of the patients. The second part of the guideline, published separately, addresses the systemic therapy of AD.
KW - atopic dermatitis
KW - atopic eczema
KW - eczema
UR - http://www.scopus.com/inward/record.url?scp=85181254307&partnerID=8YFLogxK
U2 - 10.1111/ddg.15230
DO - 10.1111/ddg.15230
M3 - Article
AN - SCOPUS:85181254307
SN - 1610-0379
JO - JDDG - Journal of the German Society of Dermatology
JF - JDDG - Journal of the German Society of Dermatology
ER -